APO Research
Talk to an analyst

APO RESEARCH · REPORT

Selective Serotonin Reuptake Inhibitors (SSRIs)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025189 pages

Choose your research edition.

Industry ResearchSelective Serotonin Reuptake Inhibitors (SSRIs) Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Selective Serotonin Reuptake Inhibitors (SSRIs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Selective Serotonin Reuptake Inhibitors (SSRIs) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Selective Serotonin Reuptake Inhibitors (SSRIs) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Selective Serotonin Reuptake Inhibitors (SSRIs) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Selective Serotonin Reuptake Inhibitors (SSRIs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Selective Serotonin Reuptake Inhibitors (SSRIs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Selective Serotonin Reuptake Inhibitors (SSRIs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Selective Serotonin Reuptake Inhibitors (SSRIs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Selective Serotonin Reuptake Inhibitors (SSRIs) include Allergan Plc, H. Lundbeck AS, GlaxoSmithKline Plc, Pfizer Inc. and Eli Lilly and Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Selective Serotonin Reuptake Inhibitors (SSRIs) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Selective Serotonin Reuptake Inhibitors (SSRIs) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Selective Serotonin Reuptake Inhibitors (SSRIs) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Selective Serotonin Reuptake Inhibitors (SSRIs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Selective Serotonin Reuptake Inhibitors (SSRIs) Segment by Company

Allergan Plc

H. Lundbeck AS

GlaxoSmithKline Plc

Pfizer Inc.

Eli Lilly and Co.

Selective Serotonin Reuptake Inhibitors (SSRIs) Segment by Type

Citalopram (Celexa)

Sertraline (Zoloft)

Paroxetine (Paxil, Pexeva)

Fluoxetine (Prozac)

Vilazodone (Viibryd)

Escitalopram (Lexapro)

Selective Serotonin Reuptake Inhibitors (SSRIs) Segment by Application

Depression

Other mental conditions

Anxiety and panic disorder

Selective Serotonin Reuptake Inhibitors (SSRIs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Selective Serotonin Reuptake Inhibitors (SSRIs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Selective Serotonin Reuptake Inhibitors (SSRIs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Selective Serotonin Reuptake Inhibitors (SSRIs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Selective Serotonin Reuptake Inhibitors (SSRIs) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Selective Serotonin Reuptake Inhibitors (SSRIs) industry.

Chapter 3: Detailed analysis of Selective Serotonin Reuptake Inhibitors (SSRIs) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Selective Serotonin Reuptake Inhibitors (SSRIs)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Citalopram (Celexa) Table 3. Key Players of Sertraline (Zoloft) Table 4. Key Players of Paroxetine (Paxil, Pexeva) Table 3. Key Players of Fluoxetine (Prozac) Table 4. Key Players of Vilazodone (Viibryd) Table 5. Key Players of Escitalopram (Lexapro) Table 6. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Depression Table 8. Key Players of Other mental conditions Table 9. Key Players of Anxiety and panic disorder Table 10. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Region (2021-2026) Table 13. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Region (2027-2032) Table 15. Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Trends Table 16. Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Drivers Table 17. Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Opportunities and Challenges Table 18. Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Restraints Table 19. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Company (2021-2026) Table 21. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Key Company Head Office and Area Served Table 23. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Company, Product Type & Application Table 24. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Selective Serotonin Reuptake Inhibitors (SSRIs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Type (2021-2026) Table 31. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Type (2027-2032) Table 32. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Application (2021-2026) Table 36. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Application (2027-2032) Table 37. Allergan Plc Company Information Table 38. Allergan Plc Business Overview Table 39. Allergan Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Allergan Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio Table 41. Allergan Plc Recent Development Table 42. H. Lundbeck AS Company Information Table 43. H. Lundbeck AS Business Overview Table 44. H. Lundbeck AS Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. H. Lundbeck AS Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio Table 46. H. Lundbeck AS Recent Development Table 47. GlaxoSmithKline Plc Company Information Table 48. GlaxoSmithKline Plc Business Overview Table 49. GlaxoSmithKline Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. GlaxoSmithKline Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio Table 51. GlaxoSmithKline Plc Recent Development Table 52. Pfizer Inc. Company Information Table 53. Pfizer Inc. Business Overview Table 54. Pfizer Inc. Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Pfizer Inc. Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio Table 56. Pfizer Inc. Recent Development Table 57. Eli Lilly and Co. Company Information Table 58. Eli Lilly and Co. Business Overview Table 59. Eli Lilly and Co. Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Eli Lilly and Co. Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio Table 61. Eli Lilly and Co. Recent Development Table 62. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026) & (US$ Million) Table 63. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032) & (US$ Million) Table 64. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026) & (US$ Million) Table 65. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032) & (US$ Million) Table 66. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 67. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021-2026) Table 68. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2027-2032) Table 69. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026) & (US$ Million) Table 70. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032) & (US$ Million) Table 71. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026) & (US$ Million) Table 72. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032) & (US$ Million) Table 73. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021-2026) Table 75. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2027-2032) Table 76. China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026) & (US$ Million) Table 77. China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032) & (US$ Million) Table 78. China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026) & (US$ Million) Table 79. China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032) & (US$ Million) Table 80. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026) & (US$ Million) Table 81. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032) & (US$ Million) Table 82. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026) & (US$ Million) Table 83. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032) & (US$ Million) Table 84. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021-2026) Table 86. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2027-2032) Table 87. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026) & (US$ Million) Table 88. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032) & (US$ Million) Table 89. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026) & (US$ Million) Table 90. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032) & (US$ Million) Table 91. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021-2026) Table 93. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2027-2032) Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Selective Serotonin Reuptake Inhibitors (SSRIs) Product Image Figure 2. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type: 2025 VS 2032 Figure 4. Citalopram (Celexa) Image Figure 5. Sertraline (Zoloft) Image Figure 6. Paroxetine (Paxil, Pexeva) Image Figure 7. Fluoxetine (Prozac) Image Figure 8. Vilazodone (Viibryd) Image Figure 9. Escitalopram (Lexapro) Image Figure 10. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application: 2025 VS 2032 Figure 12. Depression Image Figure 13. Other mental conditions Image Figure 14. Anxiety and panic disorder Image Figure 15. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 17. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Selective Serotonin Reuptake Inhibitors (SSRIs) Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Type (2021-2032) Figure 24. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Application (2021-2032) Figure 26. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 27. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032) Figure 28. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032) Figure 29. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2021-2032) Figure 30. United States Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 31. Canada Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 33. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 34. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032) Figure 35. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032) Figure 36. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2021-2032) Figure 37. Germany Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 38. France Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 40. Italy Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 41. Russia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 43. China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 44. China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032) Figure 45. China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032) Figure 46. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 47. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032) Figure 48. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032) Figure 49. Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2021-2032) Figure 50. Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 54. India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 55. Australia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2021-2032) Figure 60. Brazil Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 65. UAE Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 67. Chile Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Citalopram (Celexa)
  • Sertraline (Zoloft)
  • Paroxetine (Paxil, Pexeva)
  • Fluoxetine (Prozac)
  • Vilazodone (Viibryd)
  • Escitalopram (Lexapro)
Applications
  • Depression
  • Other mental conditions
  • Anxiety and panic disorder
Companies covered
  • Allergan Plc
  • H. Lundbeck AS
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Eli Lilly and Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Citalopram (Celexa)
  5. 1.2.3 Sertraline (Zoloft)
  6. 1.2.4 Paroxetine (Paxil, Pexeva)
  7. 1.2.5 Fluoxetine (Prozac)
  8. 1.2.6 Vilazodone (Viibryd)
  9. 1.2.7 Escitalopram (Lexapro)
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Depression
  13. 1.3.3 Other mental conditions
  14. 1.3.4 Anxiety and panic disorder
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Growth Trends by Region
  17. 1.5.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2021-2026)
  19. 1.5.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Dynamics
  1. 2.1 Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Trends
  2. 2.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Drivers
  3. 2.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Opportunities and Challenges
  4. 2.4 Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue by Company (2021-2026)
  2. 3.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Key Company Head office and Area Served
  4. 3.4 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Company, Product Type & Application
  5. 3.5 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Selective Serotonin Reuptake Inhibitors (SSRIs) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Selective Serotonin Reuptake Inhibitors (SSRIs) Tier 1, Tier 2, and Tier 3
4 Selective Serotonin Reuptake Inhibitors (SSRIs) Market by Type
  1. 4.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2032)
  3. 4.3 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Share by Type (2021-2032)
5 Selective Serotonin Reuptake Inhibitors (SSRIs) Market by Application
  1. 5.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2032)
  3. 5.3 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Allergan Plc
  2. 6.1.1 Allergan Plc Company Information
  3. 6.1.2 Allergan Plc Business Overview
  4. 6.1.3 Allergan Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Allergan Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio
  6. 6.1.5 Allergan Plc Recent Developments
  7. 6.2 H. Lundbeck AS
  8. 6.2.1 H. Lundbeck AS Company Information
  9. 6.2.2 H. Lundbeck AS Business Overview
  10. 6.2.3 H. Lundbeck AS Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 H. Lundbeck AS Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio
  12. 6.2.5 H. Lundbeck AS Recent Developments
  13. 6.3 GlaxoSmithKline Plc
  14. 6.3.1 GlaxoSmithKline Plc Company Information
  15. 6.3.2 GlaxoSmithKline Plc Business Overview
  16. 6.3.3 GlaxoSmithKline Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GlaxoSmithKline Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio
  18. 6.3.5 GlaxoSmithKline Plc Recent Developments
  19. 6.4 Pfizer Inc.
  20. 6.4.1 Pfizer Inc. Company Information
  21. 6.4.2 Pfizer Inc. Business Overview
  22. 6.4.3 Pfizer Inc. Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Inc. Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio
  24. 6.4.5 Pfizer Inc. Recent Developments
  25. 6.5 Eli Lilly and Co.
  26. 6.5.1 Eli Lilly and Co. Company Information
  27. 6.5.2 Eli Lilly and Co. Business Overview
  28. 6.5.3 Eli Lilly and Co. Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Eli Lilly and Co. Selective Serotonin Reuptake Inhibitors (SSRIs) Product Portfolio
  30. 6.5.5 Eli Lilly and Co. Recent Developments
7 North America
  1. 7.1 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032)
  2. 7.2 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
  3. 7.2.1 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026)
  4. 7.2.2 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032)
  5. 7.2.3 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032)
  6. 7.3 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
  7. 7.3.1 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026)
  8. 7.3.2 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032)
  9. 7.3.3 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032)
  10. 7.4 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country
  11. 7.4.1 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021-2026)
  13. 7.4.3 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2027-2032)
  14. 7.4.4 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032)
  2. 8.2 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
  3. 8.2.1 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032)
  6. 8.3 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
  7. 8.3.1 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032)
  10. 8.4 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country
  11. 8.4.1 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032)
  2. 9.2 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
  3. 9.2.1 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026)
  4. 9.2.2 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032)
  5. 9.2.3 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032)
  6. 9.3 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
  7. 9.3.1 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026)
  8. 9.3.2 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032)
  9. 9.3.3 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032)
  2. 10.2 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
  3. 10.2.1 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032)
  6. 10.3 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
  7. 10.3.1 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032)
  10. 10.4 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country
  11. 10.4.1 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst